News

Bharat Biotech, Ocugen expand COVAXIN commercialization rights to include Canada

Ocugen to have exclusive co-development, manufacturing, and commercialization rights to COVAXIN in Canada, in addition to its existing US rights

Jun 09, 2021

By : Team ABLE

Incubator BBC gets DSIR Recognition

ABLE’s Patron Gold member, Bangalore Bioinnovation Centre (BBC), is now recognized as the Scientific & Industrial Research Organization (SIRO) by the Department of Scientific and Industrial Research (DSIR)

Jun 09, 2021

By : Team ABLE

Biocon ties up with Belagavi-based manufacturer to make Remdesivir

Belagavi-based pharmaceutical company has been roped in to manufacture ‘Remidesvir’, which is given to critical Covid patients and is in short supply across the country

Jun 09, 2021

By : Team ABLE

ABLE & Biocon Chief contributes Rs 5 cr for pandemic research to Ignite Life Science Foundation

Dr Kiran Mazumdar-Shaw contributes toward the initial pool of funding for the research projects on “Pandemic Preparedness”

Jun 07, 2021

By : Team ABLE

BBC startup announces CD4 Shield to mitigate COVID-19

Bangalore-based Stabicon, which is incubated at Bangalore Bioinnoavtion Centre (BBC), has launched CD4 Shield. The start-up has been working on prevention program for the novel coronavirus (nCOV-19) using the company’s proprietary Zuicel technology.

Jun 03, 2021

By : Team ABLE

 

Archives